The loss of PTEN expression may be an important early factor in endometrial carcinogenesis, and Yang et al. found that the loss of PTEN was reported in about 55% of endometrial cancer tissues, which may be related to the loss of mitotic function inhibited by insulin growth factor (Yang et al., 2015). This evidence concerns the gene PTEN and endometrial cancer.